幽门螺杆菌（Helicobacter pylori, Hp）是一种与人类共生数万年的螺旋状革兰阴性菌，被称为“胃部的隐形杀手”。全球约有一半人口感染Hp，尤其在中低收入国家，感染率居高不下。根据国家消化病临床研究中心的筛查结果， ...

幽门螺杆菌（Helicobacter pylori，H. pylori）是一种微需氧的革兰氏阴性菌，生命力顽强，能在酸性的胃部环境中生存，主要寄居于胃黏膜 。它就像隐藏在胃部的 “小怪兽”，一旦感染，可能伴随人一生，即便经过治疗将其 “赶跑”，也有复发的可能。

Cite this: New Concepts of Resistance in the Treatment of Helicobacter pylori Infections - Medscape - Jun 01, 2008. Summary and Introduction A History of Treatment for H. pylori Infections ...

Table 1. Recommended Treatments for Helicobacter pylori Eradication 23 Regimen Duration (days) Eradication Rates (%) Potential Reasons for Failure; Clarithromycin 500 mg 2 times/day + amoxicillin ...

New guideline for Helicobacter pylori includes change to primary treatment recommendation. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 09 / 240904184524.htm ...

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...

Helicobacter pylori treatment practices in the Asia-Pacific region. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250318141617.htm ...

Discover how atrophic gastritis silently damages stomach tissue while increasing cancer risk, often going undiagnosed for years.

The global helicobacter pylori infections treatment market is on a robust growth trajectory, with its value projected to escalate from USD 638.3 million in 2023 to an impressive USD 1,260 million by ...